3. Fixed and modifiable risk factors for breast cancer

International Journal of Clinical Practice

Volumn 55, Issue 8, 2001, Pages 527-530

  Fentiman, I S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; ESTROGEN; ORAL CONTRACEPTIVE AGENT; STEROID;

ALCOHOL CONSUMPTION; ARTICLE; BENIGN TUMOR; BODY HEIGHT; BODY WEIGHT; BREAST CANCER; BREAST HYPERPLASIA; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; DIET; DNA REPAIR; EXERCISE; FEMALE; GENE MUTATION; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; INHERITANCE; IONIZING RADIATION; LACTATION; LIFESTYLE; MENARCHE; NULLIPARA; ORAL CONTRACEPTION; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; TUMOR PROMOTION; ADOLESCENT; ADULT; AGED; BODY CONSTITUTION; BREAST TUMOR; GENETIC PREDISPOSITION; MIDDLE AGED; PHYSIOLOGY; REVIEW;

ADOLESCENT; ADULT; AGED; BODY CONSTITUTION; BREAST NEOPLASMS; DIET; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE STYLE; MIDDLE AGED; RADIATION, IONIZING; RISK FACTORS; STEROIDS;

EID: 0034740353     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Moclan B, Chetrit A, Alfandary E et al. Increased risk of breast cancer after low-dose irradiation. Lancet 1989; ii: 629-631.
2. Hildreth NG, Shore RE, Dvoretsky PM. The risk of breast cancer after irradiation of the thymus in infancy. N Eng! J Med 1989; 321: 1281-1284.
3. Lundell M, Mattsson A, Hakulinen T, Holm L-E. Breast cancer after radiotherapy for skin hemangioma in infancy. Radiation Res 1996; 145: 225-230.
4. Shore RE, Hempelmann, Kowaluk E et al. Breast neoplasms in women treated with X-rays for acute postpartum mastitis. J Nat/ Cancer lust 1977; 59:913-922.
5. Mattsson A, Ruden B-1, Hall P et al. Radiation-induced breast cancer: longterm follow-up of radiation therapy for benign breast disease. J Natl Cancer lust 1993:85: 1679-1685.
6. Hrubec Z, Boice JD. Monson RR, Rosenstein M. Breast cancer after multiple chest fluoroscopies: second follow-up of Massachusetts women with tuberculosis. Cancer Res 1989; 49: 229-234.
7. Buell P. Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 1973:51: 1479-1483.
8. Graham S, Marshall J, Mettlin C et al. Diet in the epidemiology of breast cancer. Am J Epidemiol 1982; 116: 68-75.
9. Talamini R, La Vecchia CL, Decarli A el at. Social factors, diet and breast cancer in a northern Italian population. Br J Cancer 1984; 49: 723-729.
10. Hunter DJ, Spiegelman D, Adami H-O et al. Cohort studies of fat intake and the risk of breast cancer: a pooled analysis. N Engl J Med 1996: 334: 356-361.
11. London SJ, Colditz GA, Stampfer MJ et al. Prospective study of relative weight, height, and risk of breast cancer. JAMA 1989; 262: 2853-2858.
12. Ziegler RG, Hoover RN, Nomura AMY et al. Relative weight, weight change, height, and breast cancer risk in Asian-American women. J Natl Cancer Inst 1996; 88: 650-660.
13. Sellers TA. Kushi LH. Potter JD et al. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med 1992; 326: 1323-1329.
14. Grodin JM, Siiteri PK. MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endacrinol Metab 1973; 36: 207-214.
15. Wang DY, De Stavola BL, Alien DS et al. Breast cancer risk is positively associated with height. Breast Cancer Re Treat 1997: 43: 123-128.
16. Schatzkin A, Longnecker MP. Alcohol and breast cancer: where are we now and where do we go from here? Cancer 1994: 74: 1101-1110.
17. Willet W, Stampfer MJ, Bain C et al. Cigarette smoking, relative weight and menopause. Am J Epidemiol 1983; 117: 651-658.
18. Vatten LJ, Kvinnsland S. Cigarette smoking and risk of breast cancer: a prospective study of 24,239 Norwegian women. Kur J Cancer 1990; 26: 830-833.
19. Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW. Cigarette smoking and risk of fatal breast cancer. Am J Epidemiol 1994; 139: 1001-1007.
20. Hsieh C-C, Trichopoulos D, Katsouyanni K, Yuasa S. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. In! J Cancer 1990:46: 796-800.
21. Parazzini F. La Vecchia C, Negri E et al. Lifelong menstrual pattern and risk of breast cancer. Oncology 1993: 50: 222-225.
22. Salber EJ, Trichopoulos D, MacMahon B. Lactation and reproductive histories of breast cancer patients in Boston, 1965-66. J Natl Cancer Inst 1969; 43: 1013-1024.
23. Enger SM, Ross RK, Henderson BE, Bernstein L. Breastfeeding history, pregnancy experience and risk of breast cancer. Br J Cancer 1997; 76: 118123.
24. Trichopoulos D, MacMahon B. Menopause and breast cancer risk, y Natl Cancer lust 1972; 48: 605-613.
25. Key TJA, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer din Oncol 1988; 24: 29-43.
26. Key TJA, Wang DY, Brown JB el al. A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer 1996; 73: 1615-1619.
27. Wang DY, De Stavola BL, Bulbrook RD et al. The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. Eur J Cancer Clin Oncol 1988; 24: 1225-1231.
28. Wang DY, De Stavola BL, Bulbrook RD et al. Relationship of blood prolactin levels and the risk of subsequent breast cancer. Int J Epidemiol 1992; 21: 214-221.
29. Holdaway IM, Mason BH, Gibbs EE et al. Seasonal changes in serum melatonin in women with previous breast cancer. Br J Cancer 1991 ; 64: 149-153.
30. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative re-analysis of individual data on 53.297 women with breast cancer and 100.239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347: 1713-1727.
31. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52.705 women with breast cancer and 108.411 women without breast cancer. Lancet 1997; 350: 1047-1059.
32. Frisch RE, Wyshak G, Albright NL et al. Lower lifetime occurrence of breast cancer and cancers of the reproductive system among former college athletes. Am J Clin Nutr 1987; 45: 328-335.
33. Bernstein L, Ross RK. Lobo RA et al. The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention. Br y Cancer I987;55: 681-685.
34. Miki Y. Swensen J. Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
35. Wooster R, Bignell G, Lancaster G et al. Identification of the breast cancer gene BRCA2. Nature 1995; 378: 789-791.
36. Ford D, Easton DF, Bishop DT et al. Risks of cancer in BRCA1 mutation carriers. Lancet 1994; 343: 692-695.
37. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engt J Med 1985; 312: 146-151.
38. Tavassoli FA. Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990; 65: 518-529.
39. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992; 267: 941-944.
40. Haagensen CD. Diseases of the breast. 3rd edn. Philadelphia: WB Saunders, 1986.
41. Dupont WD. Pari FF, Hartmann WH et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993; 71: 1258-1265.